Urodynamic Efficacy and Safety of Mirabegron Add‐on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder

By  

LUTS, Vol. 8, Iss. 3, 2016-09 ,pp. : 171-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study*

By Korn Dana   Brande Paul Van den   Potvin Emmanuel   Dramaix Michèle   Herbots Ella   Peché Rudi  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 489-497

Informa Healthcare

Access to resources Recommend Favorite

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

By Choi Seong Hye   Park Kyung Won   Na Duk L.   Han Hyun Jeong   Kim Eun-Joo   Shim Yong S.   Lee Jae-Hong    

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1375-1383

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study

By  

LUTS, Vol. 7, Iss. 2, 2015-05 ,pp. : 84-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study

By  

Urologia Internationalis, Vol. 97, Iss. 3, 2016-04 ,pp. : 325-329

Karger

Access to resources Recommend Favorite